Further clinical experience with low-dosage penicillamine regimens since the last penicillamine symposium confirms earlier work (Moynahan 1974), and it is now clear that the drug will not only arrest the extension of linear scleroderma and local patches of morphcea as well as coup-desabre, within a few weeks of beginning treatment, but will usually lead to complete restoration of the epidermal and dermal elements of the affected skin. However, return of subcutaneous fat is much more problematical, so that the normal contours of the limb may not be restored.
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There may also be residual shortening unless the disease is brought under control before the growth of the limb is seriously retarded.
Keloids, both thermal and spontaneous, respond well, and cosmetic appearances are almost invariably improved. Penicillamine also permits surgical excision of such treated scars so that their appearance can be still further improved; fractures heal in the normal way despite continuation of low-dosage penicillamine treatment. Good results have been obtained in two adults with lichen sclerosus et atrophicus, and a third is responding well.
Although improvement of the skin lesions in systemic sclerosis can be obtained with lowdosage penicillamine, the drug has little or no effect on the visceral lesions, where the sclerosis is almost certainly secondary to ischmmia, probably from a vasculitis, because the collagen is of a different type. On the other hand the clinical variant, acrosclerosis, responds well to the drug, since the bulk of the lesions affect skin collagen and, to a lesser extent, that of the pharynx and cesophagus. Excellent results have been obtained in the past three years in the treatment of granuloma annulare with the same regimen in children. Most lesions will clear, completely and permanently, within four to six weeks of starting treatment. The disease is rarer in adults and, although lesions on the upper limb may respond quickly, some leg lesions take longer.
Side-effects, apart from urticaria in one boy, have not been observed in over 50 children who have now been treated in this way. Skin reactions, usually over sclerotic patches, have occurred in four adult patients and may be the result of overdepletion of soluble collagen in the papillary layer of the affected dermis, but local application of hydrocortisone deals quickly with these. Aphthous stomatitis has occurred in one elderly woman patient, but this was relieved by reducing the dose of penicillamine temporarily; consistent with the view that there is a slower turnover of collagen in mucose of elderly subjects, as well as in their skin.
Conclusions
It seems clear from our experience that there are very marked differences in the pharmacodynamics of penicillairnine with regard to dermal collagen in the child and the adult. It is likely that part of the difference can be attributed to the fact that dermal collagen in the child exists in a less stable equilibrium (i.e. has greater turnover) and this is reflected in the greater content of soluble collagen in this age group. It is known that soluble collagen decreases rapidly when growth of the individual ceases, and it is likely in view of the greater incidence of cutaneous side-effects in the elderly patient that there must be a very much slower turnover of collagen in the skin of this age group.
Differences in the composition of tissue collagen clearly affect the response to penicillamine. This is especially prominent in systemic sclerosis where improvement may take place in the skin lesions, whereas the intimate collagen of viscera such as the heart, lungs or liver remains unaffected. Acrosclerosis, in which the collagen changes are restricted to the distal parts of the limbs, bucco-pharyngeal and aesophageal mucosae, i.e. tissues affected in dystrophic epidermolysis bullosa, also responds to penicillamine; and incidentally these are the sites of soft tissue calcification.
It is clear, therefore, that penicillamine will produce phenocopies of inherited disorders, including some variants of the Ehlers-Danlos syndrome as well as the dystrophic epidermolysis bullosa also mentioned. It therefore behoves the clinician to rule out the nosomimetic action of the drug before he diagnoses a potentially serious disease. This applies with special force to the pemphigus-like lesions which have recently been reported, most of which may well represent the chelating effect of the drug, possibly on a trace metal controlling the enzyme(s) which play a prominent part in the production of the glycoaminoglycans (chondroitin sulphates and hyaluronidase) in the epidermis, which would account for the prompt relief of a majority ofthese patients when penicillamine is withdrawn.
DISCUSSION
Dr S Jain (London): Has a controlled trial been carried out of the treatment of granuloma annulare with penicillamine? Has the use of the drug been controlled so that it could be proved that the skin lesion responds to the drug?
Dr Moynahan: Most of the patients I have treated are children. The only way to answer the question is to say that if treatment is stopped prematurely the disease relapses but clears completely when treatment is resumed in every case.
Dr Jain: Surely, unless a controlled trial is done it might be like the situation of the treatment of warts for many years.
Dr Moynahan: This is the same problem as that raised over the treatment of morphoea. I think it is ethically wrong to withhold a drug which may prevent a child's leg being shortened. This investigation has to be done over a period of time. The only way in which to do it is to collect a number of cases and see if they all behave in that way. There have been no failures so far in over 50 unselected cases of granuloma annulare.
Dr D N Golding (Harlow): I am interested in the comments about keloids. I would have thought that keloids contain rather a lot of crosslinked collagen.
Dr Moynahan: Work done recently in Paris shows that a great deal of the keloid is ground substance and it would seem that it is the nature of the crosslink rather than the number that is crucial. Keloids respond to penicillamine next best to granuloma annulare.
Dr Golding: Is that in children only? Dr Moynahan: No, even in adults. I have seen a striking, rare variety in a middle-aged man, for example, who developed chicken pox when undergoing flying training in Canada. More than twenty years later he started to develop linear scleroderma originating in several of his pockmarks, going across his chest like a hussar's jacket. After several years fresh lesions extended on his chest and, within two months of giving him penicillamine, there was an arrest of spread of the lesions. Within about one year it had cleared up. I saw the same illness in a West African at Guy's Hospital last year. He had this hussar's jacket type of lesion arising spontaneously, on top of which he had large keloidsexactly the same as those described by Alibert, who gave the first description of keloids.
